Constrictor responses of the rat basilar artery during diabetes mellitu

Brain Research

Volumn 783, Issue 2, 1998, Pages 326-331

  Mayhan, William G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Arginine vasopressin; Basilar artery; Brain; Endothelin 1; Rat; Stroke; Thromboxane

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN; ARGIPRESSIN; ENDOTHELIN 1; N(G) METHYLARGININE; THROMBOXANE DERIVATIVE;

ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; BASILAR ARTERY; BLOOD VESSEL TONE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; STROKE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANGIOTENSIN II; ANIMALS; ARGININE VASOPRESSIN; BASILAR ARTERY; BLOOD PRESSURE; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; ENZYME INHIBITORS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RATS; THROMBOXANES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0031910722     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01387-5     Document Type: Article

References (46)

1. Abbott R.D., Donahue R.P., MacMahon S.W., Reed D.M., Yano K. Diabetes and the risk of stroke. J. Am. Med. Assoc. 257:1987;949-952.
2. Biller J., Love B.B. Diabetes and stroke. Med. Clin. Am. 77:1993;95-110.
3. Boura A.L.A., Hodgson W.C., King R.G. Sensivity changes of the perfused hindquarters vasculature in rats with alloxan induced diabetes mellitus. Clin. Exp. Pharmacol. Physiol. 14:1987;481-487.
4. Brooks D.P., Nutting D.F., Crofton J.T., Share L. Vasopressin in rats with genetic and streptozotocin-induced diabetes. Diabetes. 38:1989;54-57.
5. Bullock G.R., Taylor S.G., Weston A.H. Influence of the vascular endothelium on agonist induced contractions and relaxations in rat aorta. Br. J. Pharmacol. 89:1986;819-830.
6. Christlieb A.R., Janka H.U., Kraus B., Gleason R.E., Icasas-Cabral E.A., Aiello L.M., Cabral B.V., Solano A. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes. 25:1976;268-274.
7. Cocks T.M., Angus J.A. Endothelium dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 305:1983;627-630.
8. Collier A., Leach J.P., McLellan A., Jardine A., Morton J.J., Small M. Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care. 15:1992;1038-1040.
9. Faraci F.M. Role of nitric oxide in regulation of basilar artery tone in vivo. Am. J. Physiol. 259:1990;H1216-H1221.
10. Fujii K., Heistad D.D., Faraci F.M. Effect of diabetes mellitus on flow-mediated and endothelium-dependent dilatation of the rat basilar artery. Stroke. 23:1992;1494-1498.
11. Haberl R.L., Anneser F., Villringer A., Einhaupl K.M. Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles. Am. J. Physiol. 258:1990;H1840-H1846.
12. Hill M.A., Larkins R.G. Altered microvascular reactivity in streptozotocin-induced diabetes in rats. Am. J. Physiol. 257:1989;H1438-H1445.
13. Jandeleit K., Rumble J., Jackson B., Cooper M.E. Mesenteric vascular angiotensin-converting enzyme is increased in experimental diabetes mellitus. Clin. Exp. Pharmacol. Physiol. 19:1992;343-347.
14. Kanmura Y., Itoh T., Kuriyama H. Mechanisms of vasoconstriction induced by 9,11-epithio-11,12-methano-thrmoboxane A2 in the rabbit coronary artery. Circ. Res. 60:1987;402-409.
15. Kanno K., Hirata Y., Shichiri M., Marumo F. Plasma endothelin-1 levels in patients with diabetes mellitus with or without vascular complication. J. Cardiovasc. Pharmacol. 17:1991;S475-S476. Suppl. 7.
16. Kawamura M., Naruse K., Ohgawara H., Hori S., Naruse M., Demura H., Suzuki N., Omori Y., Iwasaki N. Increased plasma endothelin in NIDDM patients with retinopathy. Diabetes Care. 15:1992;1396-1397.
17. G-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 103:1991;1321-1326.
18. G-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 106:1992;1035-1040.
19. Lerman A., Sandok E.K., Hildebrand F.L. Jr., Burnett J.C. Jr. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circ. 85:1992;1894-1898.
20. Mayhan W.G. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 256:1989;H621-H625.
21. Mayhan W.G. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. Am. J. Physiol. 259:1990;H1455-H1462.
22. Mayhan W.G. Effect of diabetes mellitus on responses of the basilar artery in rats to products released by platelets. Stroke. 23:1992;1499-1503.
23. Mayhan W.G. Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain Res. 760:1997;204-209.
24. Mayhan W.G., Amundsen S.M., Faraci F.M., Heistad D.D. Responses of cerebral arteries after ischemia and reperfusion in cats. Am. J. Physiol. 255:1988;H879-H884.
25. Mayhan W.G., Simmons L.K., Sharpe G.M. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 260:1991;H319-H326.
26. McNally P.G., Watt P.A.C., Rimmer T., Burden A.C., Hearnshaw J.R., Thurston H. Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin. Sci. 87:1994;31-36.
27. Nishimura Y. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats. Br. J. Pharmacol. 117:1996;1325-1333.
28. Nugent A.G., McGurk C., Hayes J.R., Johnston G.D. Impaired vasoconstriction to endothelin 1 in patients with NIDDM. Diabetes. 45:1996;105-107.
29. Parving H.-H. Renoprotective action of angiotensin-converting enzyme inhibition in diabetes mellitus. J. Cardiovasc. Pharmacol. 19:1992;S19-S24. Suppl. 6.
30. Pelligrino D.A., Albrecht R.F. Chronic hyperglycemic diabetes in the rat is associated with a selective impairment of cerebral vasodilatory responses. J. Cereb. Blood Flow Metab. 11:1991;667-677.
31. Pelligrino D.A., Koenig H.M., Wang Q., Albrecht R.F. Protein kinase C suppresses receptor-mediated pial arteriolar relaxation in the diabetic rat. Neuroreport. 5:1994;417-420.
32. Pelligrino D.A., Miletich D.J., Albrecht R.F. Diminished muscarinic receptor-mediated cerebral blood flow response in streptozotocin-treated rats. Am. J. Physiol. 262:1992;E447-E454.
33. Quilley J., McGiff J.C. Renal vascular responsiveness to arachidonic acid in experimental diabetes. Br. J. Pharmacol. 100:1990;336-340.
34. Sarubbi D., McGiff J.C., Quilley J. Renal vascular responses and eicosanoid release in diabetic rats. Am. J. Physiol. 257:1989;F762-F768.
35. Slomowitz L.A., Bergamo R., Grosvenor M., Kopple J.D. Enalapril reduces albumin excretion in diabetic patients with low levels of microalbuminuria. Am. J. Nephrol. 10:1990;457-462.
36. Smulders R.A., Stehouwer C.D.A., Olthof C.G., van Kamp G.J., Teerlink T., De Vries P.M.J.M., Donker A.J.M. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin. Sci. 87:1994;37-43.
37. Takahashi K., Ghatei M.A., Lam H.C., O'Halloran D.J., Bloom S.R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 33:1990;306-310.
38. Takayasu M., Kajita Y., Suzuki Y., Shibuya M., Sugita K., Hidaka H. A role of nitric oxide in vasomotor control of cerebral parenchymal arterioles in rats. J. Auton. Nerv. Syst. 49:1994;S63-S66.
39. Tammesild P.J., Hodgson W.C., King R.G. Increased sensitivity to endothelin-1 in isolated Krebs'-perfused kidneys of streptozotocin-diabetic rats. Clin. Exp. Pharmacol. Physiol. 19:1992;261-265.
40. Toda N., Miyazaki M. Angiotensin induced relaxation in isolated dog renal and cerebral arteries. Am. J. Physiol. 240:1981;H247-H254.
41. Toda N., Shimizu I., Okamura T., Miyazaki M. Age dependent change in the response of isolated beagle cerebral arteries to vasoactive agents. J. Cardiovasc. Pharmacol. 8:1986;681-688.
42. Trezise D.J., Drew G.M., Weston A.H. Analysis of the depressant effect of the endothelium on contractions of rabbit isolated basilar artery to 5-hydroxytryptamine. Br. J. Pharmacol. 106:1992;587-592.
43. Valentovic M.A., Elliott C.W., Ball J.G. The effect of streptozotocin induced diabetes and insulin treatment on angiotensin converting enzyme activity. Res. Comm. Chem. Path. Pharmacol. 58:1987;27-39.
44. Wei E.P., Kontos H.A., Patterson J.L. Vasoconstrictor effect of angiotensin on pial arteries. Stroke. 9:1978;487-489.
45. Zannella M.T., Freire M.B.S., Milagres R., Ferreira S., Bonomo P.P., Kohlmann O., Ribeiro A.B. Blood pressure disturbance in diabetes mellitus. J. Hypertension. 10:1992;S59-S70.
46. Zhang J., Pfaffendorf M., Zhang J.S., van Zwieten P.A. Influence of the vascular endothelium on angiotensin II-induced contractions in rabbit renal artery. Fundam. Clin. Pharmacol. 9:1995;25-29.